Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases

Autor: Bereczky, Zsuzsanna, Gindele, Réka, Fiatal, Szilvia, Speker, Marianna, Miklós, Tünde, Balogh, László, Mezei, Zoltán, Szabó, Zsuzsanna, Ádány, Róza

Publikováno v: Frontiers in Cardiovascular Medicine

Background: Antithrombin (AT) is one of the most important regulator of hemostasis. AT Budapest 3 (ATBp3) is a prevalent type II heparin-binding site (IIHBS) deficiency due to founder effect. Thrombosis is a complex disease including arterial (ATE) a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ed2f9e91d3fa0f8d68d91a36757d850a
http://europepmc.org/articles/PMC7892435

Deficiencies of the Natural Anticoagulants - Novel Clinical Laboratory Aspects of Thrombophilia Testing.

Autor: Bereczky Z; University of Debrecen, Division of Clinical Laboratory Research , Department of Laboratory Medicine, Faculty of Medicine, Debrecen, Hungary., Gindele R; University of Debrecen, Division of Clinical Laboratory Research , Department of Laboratory Medicine, Faculty of Medicine, Debrecen, Hungary., Speker M; University of Debrecen, Division of Clinical Laboratory Research , Department of Laboratory Medicine, Faculty of Medicine, Debrecen, Hungary., Kállai J; University of Debrecen, Division of Clinical Laboratory Research , Department of Laboratory Medicine, Faculty of Medicine, Debrecen, Hungary.

Publikováno v: EJIFCC [EJIFCC] 2016 Apr 20; Vol. 27 (2), pp. 130-46. Date of Electronic Publication: 2016 Apr 20 (Print Publication: 2016).